>
pdufa.bio

NXC-201

Updated ยทnext FDA decision on the calendar

NXC-201 is a Immix Biopharma, Inc. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

IMMX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Immix Biopharma, Inc. (IMMX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026IMMX

Questions

When is NXC-201's next FDA decision or readout?

The next tracked catalyst for NXC-201 is a Readout in Q3 2026.

What happened at NXC-201's most recent FDA decision?

No FDA decision for NXC-201 is in our archive yet.

Who makes NXC-201?

Immix Biopharma, Inc. (IMMX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.